- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/67 - 2-Methyl-3-hydroxy-4,5-bis (hydroxy-methyl) pyridine, i.e. pyridoxine
Patent holdings for IPC class C07D 213/67
Total number of patents in this class: 17
10-year publication summary
|
1
|
3
|
1
|
2
|
0
|
0
|
0
|
2
|
1
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Givaudan SA | 1961 |
2 |
| Lucid Psycheceuticals Inc. | 10 |
2 |
| Aequus Pharmaceuticals Inc. | 3 |
1 |
| Alcobra Ltd. | 6 |
1 |
| Epicentrx, Inc. | 84 |
1 |
| Evrogen JSC | 3 |
1 |
| Northern Innovations and Formulations Corp. | 16 |
1 |
| Bioflash inc | 3 |
1 |
| Sen-jam Pharmaceutical LLC | 11 |
1 |
| AO "tatkhimfarmpreparaty" | 3 |
1 |
| Kazan Federal University | 3 |
1 |
| Aktsionernoe Obshchestvo "tatkhimfarmpreparaty" | 6 |
1 |
| Federal'noe Gosudarstvennoe Avtonomnoe Obrazovatel'noe Uchrezhdenie Vysshego Obrazovaniya "kazanskij (privolzhskij) Federal'nyj Universitet" | 6 |
1 |
| Firmiana Health Sciences Inc. | 1 |
1 |
| Sen-jam Pharmaceutical Inc. | 18 |
1 |
| Other owners | 0 |